Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
T Yoshino, G Pentheroudakis, S Mishima, et al.
Hiroshima Journal of Medical Sciences
|
September 1, 1979
Incidence of "atypical" mycobacteria and pulmonary "atypical" mycobacterioses in National Sanatoria in the Chugoku-Shikoku area
H Saito, T Watanabe, S Akamatsu, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience
U Okazaki, I Nakayama, N Sakamoto, et al.
Case Reports in Gastroenterology
|
May 14, 2015
Diffuse Liver Metastasis of Small-Cell Lung Cancer Presenting as Acute Liver Failure and Diagnosed by Transjugular Liver Biopsy: A Rare Case in Whom Nodular Lesions Were Detected by Enhanced CT Examination
S Mishima, Y Nozaki, S Mikami, et al.
ESMO Open
|
June 13, 2025
Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma
S Sato, S L Rhodes, Y Aoki, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer
D Okemoto, I Nakayama, A Jubashi, et al.
ESMO Open
|
October 1, 2025
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer
K Yamamoto, Y Owaki, I Nakayama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 2024
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY
K Kataoka, K Mori, Y Nakamura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 19, 2021
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
T Yoshino, G Argilés, E Oki, et al.
ESMO Open
|
May 26, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
T Yoshino, A Cervantes, H Bando, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 10, 2020
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
T Yoshino, G Pentheroudakis, S Mishima, et al.
Hiroshima Journal of Medical Sciences
|
September 1, 1979
Incidence of "atypical" mycobacteria and pulmonary "atypical" mycobacterioses in National Sanatoria in the Chugoku-Shikoku area
H Saito, T Watanabe, S Akamatsu, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience
U Okazaki, I Nakayama, N Sakamoto, et al.
Case Reports in Gastroenterology
|
May 14, 2015
Diffuse Liver Metastasis of Small-Cell Lung Cancer Presenting as Acute Liver Failure and Diagnosed by Transjugular Liver Biopsy: A Rare Case in Whom Nodular Lesions Were Detected by Enhanced CT Examination
S Mishima, Y Nozaki, S Mikami, et al.
ESMO Open
|
June 13, 2025
Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma
S Sato, S L Rhodes, Y Aoki, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer
D Okemoto, I Nakayama, A Jubashi, et al.
ESMO Open
|
October 1, 2025
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer
K Yamamoto, Y Owaki, I Nakayama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 2024
Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY
K Kataoka, K Mori, Y Nakamura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 19, 2021
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
T Yoshino, G Argilés, E Oki, et al.
ESMO Open
|
May 26, 2023
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
T Yoshino, A Cervantes, H Bando, et al.
Page
of 13